Market Research Logo

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Rabies Vaccine Market 2018, Forecast to 2023

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Rabies Vaccine Market 2018, Forecast to 2023

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Scope of the Report:
This report focuses on the Rabies Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
The most wildly used rabies vaccine is Vero cell rabies vaccine (VRV), which takes about 80.85% in 2016.
Nowadays, global rabies vaccine production is mainly concentrated in China, Europe and North America. In 2016, China rabies vaccine production takes about 74.34% and Europe production takes about 7.46%.
The worldwide market for Rabies Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Other

Market Segment by Applications, can be divided into
Pre-exposure Prophylaxis
Post-exposure Prophylaxis

There are 15 Chapters to deeply display the global Rabies Vaccine market.
Chapter 1, to describe Rabies Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Rabies Vaccine, with sales, revenue, and price of Rabies Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Rabies Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Rabies Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Rabies Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Vero Cell Rabies Vaccine
1.2.2 BHK
1.2.3 Chick Embryo Cell Rabies Vaccine
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Pre-exposure Prophylaxis
1.3.2 Post-exposure Prophylaxis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK (Novartis)
2.1.1 Business Overview
2.1.1.1 GSK (Novartis) Description
2.1.1.2 GSK (Novartis) Headquarter, Main Business and Finance Overview
2.1.2 GSK (Novartis) Rabies Vaccine Product Introduction
2.1.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.1.2.2 Rabies Vaccine Product Information
2.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global GSK (Novartis) Rabies Vaccine Market Share in 2017
2.2 Sanofi-Pasteur
2.2.1 Business Overview
2.2.1.1 Sanofi-Pasteur Description
2.2.1.2 Sanofi-Pasteur Headquarter, Main Business and Finance Overview
2.2.2 Sanofi-Pasteur Rabies Vaccine Product Introduction
2.2.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.2.2.2 Rabies Vaccine Product Information
2.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Sanofi-Pasteur Rabies Vaccine Market Share in 2017
2.3 Chengda
2.3.1 Business Overview
2.3.1.1 Chengda Description
2.3.1.2 Chengda Headquarter, Main Business and Finance Overview
2.3.2 Chengda Rabies Vaccine Product Introduction
2.3.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.3.2.2 Rabies Vaccine Product Information
2.3.3 Chengda Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Chengda Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Chengda Rabies Vaccine Market Share in 2017
2.4 Yisheng
2.4.1 Business Overview
2.4.1.1 Yisheng Description
2.4.1.2 Yisheng Headquarter, Main Business and Finance Overview
2.4.2 Yisheng Rabies Vaccine Product Introduction
2.4.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.4.2.2 Rabies Vaccine Product Information
2.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Yisheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Yisheng Rabies Vaccine Market Share in 2017
2.5 Prcmise
2.5.1 Business Overview
2.5.1.1 Prcmise Description
2.5.1.2 Prcmise Headquarter, Main Business and Finance Overview
2.5.2 Prcmise Rabies Vaccine Product Introduction
2.5.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.5.2.2 Rabies Vaccine Product Information
2.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Prcmise Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Prcmise Rabies Vaccine Market Share in 2017
2.6 VACN
2.6.1 Business Overview
2.6.1.1 VACN Description
2.6.1.2 VACN Headquarter, Main Business and Finance Overview
2.6.2 VACN Rabies Vaccine Product Introduction
2.6.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.6.2.2 Rabies Vaccine Product Information
2.6.3 VACN Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 VACN Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global VACN Rabies Vaccine Market Share in 2017
2.7 Changsheng
2.7.1 Business Overview
2.7.1.1 Changsheng Description
2.7.1.2 Changsheng Headquarter, Main Business and Finance Overview
2.7.2 Changsheng Rabies Vaccine Product Introduction
2.7.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.7.2.2 Rabies Vaccine Product Information
2.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Changsheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Changsheng Rabies Vaccine Market Share in 2017
2.8 BCHT
2.8.1 Business Overview
2.8.1.1 BCHT Description
2.8.1.2 BCHT Headquarter, Main Business and Finance Overview
2.8.2 BCHT Rabies Vaccine Product Introduction
2.8.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.8.2.2 Rabies Vaccine Product Information
2.8.3 BCHT Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 BCHT Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global BCHT Rabies Vaccine Market Share in 2017
2.9 Hissen
2.9.1 Business Overview
2.9.1.1 Hissen Description
2.9.1.2 Hissen Headquarter, Main Business and Finance Overview
2.9.2 Hissen Rabies Vaccine Product Introduction
2.9.2.1 Rabies Vaccine Production Bases, Sales Regions and Major Competitors
2.9.2.2 Rabies Vaccine Product Information
2.9.3 Hissen Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Hissen Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Hissen Rabies Vaccine Market Share in 2017
3 Global Rabies Vaccine Market Competition, by Manufacturer
3.1 Global Rabies Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Rabies Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Rabies Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Rabies Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 Rabies Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Rabies Vaccine Market Analysis by Regions
4.1 Global Rabies Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Rabies Vaccine Sales by Regions (2013-2018)
4.1.2 Global Rabies Vaccine Revenue by Regions (2013-2018)
4.2 North America Rabies Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Rabies Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Rabies Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Rabies Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Rabies Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 North America Rabies Vaccine by Countries, Type, Application and Manufacturers
5.1 North America Rabies Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Rabies Vaccine Sales by Countries (2013-2018)
5.1.2 North America Rabies Vaccine Revenue by Countries (2013-2018)
5.1.3 United States Rabies Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada Rabies Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Rabies Vaccine Sales and Growth Rate (2013-2018)
5.2 North America Rabies Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Rabies Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Rabies Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Rabies Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Rabies Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Rabies Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Rabies Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Rabies Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Rabies Vaccine Revenue and Revenue Share by Application (2013-2018)
6 Europe Rabies Vaccine by Countries, Type, Application and Manufacturers
6.1 Europe Rabies Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Rabies Vaccine Sales by Countries (2013-2018)
6.1.2 Europe Rabies Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany Rabies Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK Rabies Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France Rabies Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia Rabies Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy Rabies Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe Rabies Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Rabies Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Rabies Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Rabies Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Rabies Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Rabies Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Rabies Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Rabies Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Rabies Vaccine Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Rabies Vaccine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Rabies Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Rabies Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Rabies Vaccine Revenue by Countries (2013-2018)
7.1.3 China Rabies Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan Rabies Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea Rabies Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India Rabies Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Rabies Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Rabies Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Rabies Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Rabies Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Rabies Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Rabies Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Rabies Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Rabies Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Rabies Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Rabies Vaccine Revenue and Revenue Share by Application (2013-2018)
8 South America Rabies Vaccine by Countries, Type, Application and Manufacturers
8.1 South America Rabies Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Rabies Vaccine Sales by Countries (2013-2018)
8.1.2 South America Rabies Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil Rabies Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Rabies Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Rabies Vaccine Sales and Growth Rate (2013-2018)
8.2 South America Rabies Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Rabies Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Rabies Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Rabies Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Rabies Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Rabies Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Rabies Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Rabies Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Rabies Vaccine Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Rabies Vaccine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Rabies Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Rabies Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Rabies Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Rabies Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE Rabies Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Rabies Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Rabies Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Rabies Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Rabies Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Rabies Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Rabies Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Rabies Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Rabies Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Rabies Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Rabies Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Rabies Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Rabies Vaccine Revenue and Revenue Share by Application (2013-2018)
10 Global Rabies Vaccine Market Segment by Type
10.1 Global Rabies Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Rabies Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Rabies Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Vero Cell Rabies Vaccine Sales Growth and Price
10.2.1 Global Vero Cell Rabies Vaccine Sales Growth (2013-2018)
10.2.2 Global Vero Cell Rabies Vaccine Price (2013-2018)
10.3 BHK Sales Growth and Price
10.3.1 Global BHK Sales Growth (2013-2018)
10.3.2 Global BHK Price (2013-2018)
10.4 Chick Embryo Cell Rabies Vaccine Sales Growth and Price
10.4.1 Global Chick Embryo Cell Rabies Vaccine Sales Growth (2013-2018)
10.4.2 Global Chick Embryo Cell Rabies Vaccine Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Rabies Vaccine Market Segment by Application
11.1 Global Rabies Vaccine Sales Market Share by Application (2013-2018)
11.2 Pre-exposure Prophylaxis Sales Growth (2013-2018)
11.3 Post-exposure Prophylaxis Sales Growth (2013-2018)
12 Rabies Vaccine Market Forecast (2018-2023)
12.1 Global Rabies Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Rabies Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Rabies Vaccine Market Forecast (2018-2023)
12.2.2 Europe Rabies Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Rabies Vaccine Market Forecast (2018-2023)
12.2.4 South America Rabies Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Rabies Vaccine Market Forecast (2018-2023)
12.3 Rabies Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Rabies Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Rabies Vaccine Market Share Forecast by Type (2018-2023)
12.4 Rabies Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Rabies Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Rabies Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report